Biocompatible devices with foam scaffolds

Details Biocompatible devices with foam scaffolds Biocompatible devices with foam scaffolds

1999-02-09

2001-05-15

Levy, Neil S. (Department: 1616)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

C424S533000, C424S534000, C424S548000, C424S549000, C424S550000, C424S557000, C424S562000, C424S569000, C424S570000, C424S572000, C424S574000, C424S577000, C523S105000, C523S112000, C523S113000, C523S122000, C523S200000, C523S218000, C524S009000, C524S010000, C524S017000, C524S020000, C524S021000, C524S001000

Reexamination Certificate

active

06231879

ABSTRACT:

TECHNICAL FIELD OF THE INVENTION
This invention relates to biocompatible devices with foam scaffolds and to methods for making and using such devices.
BACKGROUND OF THE INVENTION
This invention relates to implantable encapsulation devices for the treatment of diseases and disorders with encapsulated cells or substances such as neurotransmitters, neuromodulators, hormones, trophic factors, growth factors, analgesics, enzymes, antibodies or other biologically active molecules. In particular, the invention relates to internally-supported, biocompatible cell encapsulation devices.
One encapsulation approach has been macroencapsulation, which typically involves loading living cells into hollow fiber (or other suitable shape) devices and then sealing the extremities. The encapsulation of such cells by a selectively permeable, or “permselective”, membrane permits diffusion of the biological factors produced and secreted by the cells yet restrains the cells within a specific location. Encapsulation may also reduce or prevent host rejection in the case of xenogeneic (cross-species) or allogeneic transplantation.
Various types of cell devices are known. U.S. Pat. No. 4,892,538, to Aebischer et al. (incorporated herein by reference), discloses a selectively permeable hollow fiber membrane for cell encapsulation. U.S. Pat. No. 5,158,881, also to Aebischer et al. (incorporated herein by reference), discloses a method for encapsulating viable cells by forming a tubular extrudate around a cell suspension and sealing the tubular extrudate at intervals to define separate cell compartments joined by polymeric links. See also Mandel et al. (WO 91/00119), which refers to a selectively permeable cell closeable membrane tube for implantation in a subject having a large pore hydrophobic outer surface to encourage vascularization.
Many cell types used in encapsulated devices are of the adherent type, and (whether dividing or non-dividing) will aggregate and adhere to one another. These cell clusters or aggregations may form a necrotic core in the center of the device. Such a core may develop over time due to a shortage of certain metabolites reaching the center of the cell cluster or to the buildup of toxic products, causing cells to die. As dying cells accumulate and begin to break down, the necrotic tissue may also release factors which are detrimental to the surviving cells (e.g., factors which elicit a macrophage or other immune response).
One approach to reducing formation of a necrotic core involves immobilizing cells in a matrix material, e,g, a hydrogel matrix, within the device. See, e.g., Dionne et al. (WO 92/19195) which refers to biocompatible immunoisolatory vehicles with a hydrogel or extracellular matrix core.
Another known approach to controlling growth of cells in the device and to reducing necrotic core effects is to provide poly(hydroxyethyl methacylate) or poly(hydroxyethyl methacrylate-co-methyl methacrylate) or non-woven polyester scaffold for cells to grow on inside the device. See, e.g., Schinstine et al. (WO 96/02646). Such scaffolds form a fibrous net, not an open cell structure.
SUMMARY OF THE INVENTION
The present invention provides a new biocompatible cell device with an internal foam scaffold. The foam scaffold has an open cell structure, i.e., a structure presenting interconnected macropores. Cells can attach to the walls of the macropores. The scaffold material used in the devices of this invention is a synthetic, macroporous, polymeric, open-cell foam material. The cells contained on this scaffold material are prevented from escaping from the scaffold by encapsulation within a porous cell-impermeable membrane.


REFERENCES:
patent: 2609347 (1952-09-01), Wilson
patent: 3106483 (1963-10-01), Kline
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 4920203 (1990-04-01), Tang et al.
patent: 4921703 (1990-05-01), Higuchi et al.
patent: 4968733 (1990-11-01), Muller et al.
patent: 4976859 (1990-12-01), Wechs
patent: 5158881 (1992-10-01), Aebischer et al.
patent: 5283187 (1994-02-01), Aebischer et al.
patent: 5284761 (1994-02-01), Aebischer et al.
patent: 5464440 (1995-11-01), Johansson
patent: 5487739 (1996-01-01), Aebischer et al.
patent: 5550050 (1996-08-01), Holland et al.
patent: 5656481 (1997-08-01), Baetge et al.
patent: 6054142 (2000-04-01), Li et al.
patent: 6071530 (2000-06-01), Polson et al.
patent: WO 91/00119 (1991-01-01), None
patent: WO 92/19195 (1992-11-01), None
patent: WO 93/00128 (1993-01-01), None
patent: WO 95/01203 (1995-01-01), None
patent: WO 95/05452 (1995-02-01), None
patent: WO 96/02646 A2 (1996-02-01), None
Kydonieus, Ed. CRC pp. 15, 132-134 1982 Insect suppression with controlled release pheromone systems.
Baetge et al., PNAS 83: 5454-5458 (1986).
Baron-Van Evercooren et al., Dev. Neurosci 8: 182-196 (1986).
Cabasso, Encyclopedia of Chemical Technology 12: 492-517 (1980).
Colton et al., the Kidney, eds., Brenner BM and Rector FC, pp. 2425-2489 (1981).
Dionne et al., ASAIO Abstracts, p. 99 (1993).
Hasirci, “Polyurethanes” in High Performance Biomaterials: A Comprehensive Guide to Medical and Pharmaceutical Applications, ed.,Szycher, pp. 71-89, Techomic Publishing, Lancaster, PA (1991).
Ray et al., PNAS 90: 3602-3606 (1993).
Richards et al., PNAS 89: 8591-8595 (1992).
Southern et al., J. Mol. Appl. Genet. 1:327 (1982).
Southern, P.J., In Vitro 18: 315 (1981).

Affiliated with

Also associated with

Rating

Biocompatible devices with foam scaffolds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biocompatible devices with foam scaffolds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biocompatible devices with foam scaffolds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2569484